These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11078160)

  • 21. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy.
    Créange A; Shahrizaila N; Salhi H; Lefaucheur JP; Yuki N
    J Peripher Nerv Syst; 2014 Jun; 19(2):115-20. PubMed ID: 24750296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
    Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
    Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of anti-ganglioside antibodies in Guillain-Barré syndrome and its variants by the agglutination assay.
    Alaedini A; Briani C; Wirguin I; Siciliano G; D'Avino C; Latov N
    J Neurol Sci; 2002 Apr; 196(1-2):41-4. PubMed ID: 11959155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ganglioside reactive antibodies in the neuropathy associated with celiac disease.
    Alaedini A; Green PH; Sander HW; Hays AP; Gamboa ET; Fasano A; Sonnenberg M; Lewis LD; Latov N
    J Neuroimmunol; 2002 Jun; 127(1-2):145-8. PubMed ID: 12044986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe sensory ataxia and demyelinating polyneuropathy with IgM anti-GM2 and GalNAc-GD1A antibodies.
    Lopate G; Choksi R; Pestronk A
    Muscle Nerve; 2002 Jun; 25(6):828-36. PubMed ID: 12115971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyotrophic lateral sclerosis with IgM antibody against gangliosides GM2 and GD2.
    Mizutani K; Oka N; Kusunoki S; Kaji R; Kanda M; Akiguchi I; Shibasaki H
    Intern Med; 2003 Mar; 42(3):277-80. PubMed ID: 12705795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Guillain-Barré syndrome following cytomegalovirus infection with increased level of antibody against moesin-a case report].
    Shiga Y; Shimoe Y; Chigusa M; Kusunoki S; Mori M; Kuriyama M
    Rinsho Shinkeigaku; 2018 Jun; 58(6):385-389. PubMed ID: 29863101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acquired infantile abducens palsy associated with anti-GM2 antibodies.
    Smyth KA; Fritzler MJ; Kirton A
    Pediatr Neurol; 2011 Jun; 44(6):459-62. PubMed ID: 21555058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies against ganglioside complexes in Guillain-Barré syndrome and related disorders.
    Kusunoki S; Kaida K
    J Neurochem; 2011 Mar; 116(5):828-32. PubMed ID: 21214559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Invited review: motor neuropathies, motor neuron disorders, and antiglycolipid antibodies.
    Pestronk A
    Muscle Nerve; 1991 Oct; 14(10):927-36. PubMed ID: 1658646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiganglioside antibodies in Guillain-Barré syndrome after a recent cytomegalovirus infection.
    Khalili-Shirazi A; Gregson N; Gray I; Rees J; Winer J; Hughes R
    J Neurol Neurosurg Psychiatry; 1999 Mar; 66(3):376-9. PubMed ID: 10084538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IgM anti-GM2 antibody in a patient with Guillain-Barré syndrome subsequent to cytomegalovirus hepatitis cross reacts with N-acetylgalactosaminyl GD1a.
    Tsukaguchi M; Tagawa Y; Takeuchi H; Yuki N
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):407-8. PubMed ID: 9728970
    [No Abstract]   [Full Text] [Related]  

  • 33. Antisera against ganglioside GM2: immunochemical and immunohistological studies.
    Schwerer B; Lassmann H; Bernheimer H
    Neuropathol Appl Neurobiol; 1982; 8(3):217-26. PubMed ID: 6214725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-GM2 antibodies in Guillain-Barré syndrome with acute cytomegalovirus infection.
    Nakamura K; Irie S; Kanazawa N; Saito T; Tamai Y
    Ann N Y Acad Sci; 1998 Jun; 845():423. PubMed ID: 9668386
    [No Abstract]   [Full Text] [Related]  

  • 35. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
    Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
    Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates.
    Pestronk A; Choksi R
    Neurology; 1997 Nov; 49(5):1289-92. PubMed ID: 9371910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ganglioside characterization of a cell line displaying motor neuron-like phenotype: GM2 as a possible major ganglioside in motor neurons.
    Matsumoto A; Yoshino H; Yuki N; Hara Y; Cashman NR; Handa S; Miyatake T
    J Neurol Sci; 1995 Aug; 131(2):111-8. PubMed ID: 7595635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies.
    Nobile-Orazio E; Giannotta C; Briani C
    J Neuroimmunol; 2010 Feb; 219(1-2):119-22. PubMed ID: 20006388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies.
    Zhang G; Lopez PH; Li CY; Mehta NR; Griffin JW; Schnaar RL; Sheikh KA
    Brain; 2004 May; 127(Pt 5):1085-100. PubMed ID: 14985267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.